LawFormer Eli Lilly Sales Representative Sues Over Alleged Mounjaro MarketingBy Helena WardNov 12, 2026, 1:18 PM UTC
HealthFDA Orders GLP-1 Drug Labels to Add Warning on Rare Eye RiskBy Naomi CalderNov 9, 2026, 7:44 PM UTC
BusinessLilly Raises 2026 Revenue Outlook as Mounjaro, Zepbound Sales RiseBy Helena WardOct 29, 2026, 10:17 PM UTC